Patents Represented by Attorney Todd Lorenz
  • Patent number: 7812124
    Abstract: A method of diagnosing cancer comprising the identification of neoplastic molecular markers is disclosed. Tumor-related or neoplastic molecular markers are identified from samples taken from a subject and the molecular profile of those markers is determined. Based upon the neoplastic molecular marker profile of the subject, the tumor sub-type is ascertained and an appropriate treatment protocols initiated.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: October 12, 2010
    Inventor: Kaia Palm
  • Patent number: 7671026
    Abstract: The methods and compositions relate to treatment of disorders of the bladder. In particular, the methods provide for treatment of interstitial cystitis and related disorders. The methods further comprise treatment to affect various manifestations associated with interstitial cystitis, including, reducing histamine release, modulating Substance P expression, modulating nerve growth factor expression, modulating levels of various cytokines, and maintaining integrity of the urine/blood barrier.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: March 2, 2010
    Assignee: Sangstat Medical Corporation
    Inventors: Timothy Fong, Alexis E. Te